Esperion, aiming to reconfigure the cholesterol-lowering market, notched its first FDA approval last week for a novel drug expected to hit shelves at a rock-bottom price. Now, the company has…Read More
Popular logic says you never switch horses, or CDMOs, in the middle of the stream. Biotch Acacia Pharma had to do just that to win FDA approval of Barhemsys, its…Read More
The U.S. Food and Drug Administration on Thursday approved Biohaven Pharmaceutical Holding Co Ltd’s oral pill for relieving pain after the onset of migraine headaches, the drug developer said. The…Read More
The U.S. Food and Drug Administration on Thursday announced the first coronavirus-related drug shortage in the United States but declined to name the drug in question. The regulator said a…Read More
Hygiene and health company Essity has signed an agreement to acquire 75% of the Swedish medical solutions company ABIGO Medical AB. The company as a whole is valued at SEK 900m on…Read More
Mylan N.V today announced the remaining appointees to the inaugural 13-member Board of Directors for Viatris, the new company that will result from the combination of Mylan and Upjohn, a…Read More
With the acquisition of San Diego-based PvP Biologics and a recent deal with COUR Pharmaceuticals, Takeda Pharmaceutical is looking to become a world leader in the treatment of celiac disease and other gastrointestinal disorders….Read More
Eli Lilly’s Cyramza appears to be on its way to picking up its sixth approval from the U.S. Food and Drug Administration as a treatment for some lung cancer patients…Read More
Gilead Sciences, based in Foster City, California, announced it will launch two Phase III clinical trials of its investigational antiviral drug remdesivir in adults diagnosed with COVID-19, the disease caused by the…Read More
Ophthalmic laser-based medical products provider Iridex has launched second-generation MicroPulse P3 device for the treatment of glaucoma. The company has redesigned the MicroPulse P3 device to deliver better stability, visualisation,…Read More
Senseonics Holdings has secured approval from the US Food and Drug Administration (FDA) to extend the PROMISE sensor study of the Eversense continuous glucose monitoring (CGM) system. The regulator has…Read More
US-based medical device firm Ra Medical Systems has enrolled the first patient in clinical study of its DABRA excimer laser system for peripheral vascular stenoses. DABRA is a minimally invasive…Read More
Baxter International has secured 510(k) clearance from the US Food and Drug Administration (FDA) for its new-generation Peri-Strips Dry with Veritas Collagen Matrix (PSDV) product, dubbed as PSDV with Secure…Read More
Ekso Bionics Holdings, a leading developer of exoskeletons for medical and industrial use, today announced a collaboration with Kindred Healthcare to pilot EksoNR— the most clinically used robotic exoskeleton, in…Read More
Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing micro-systems-based wearable diagnostic devices and currently commercializing sugarBEAT® its non-invasive and flexible continuous glucose monitor…Read More
